By combining these findings, we could anticipate that I-MDSCs in CRC microenvironment are activated and recruited to tumor sites where they differentiate into mature phenotypes and become immune suppressive under the influence of MAPK- and IL-6-mediated signaling pathways. The gene discussed is IL6; the disease is neoplasm.